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Genetic variation is natural and needed for crop
improvement
The advent of agriculture about ten millennia ago, the Green
Revolution of the 1960s, and all agriculture in-between and since
were founded on identification and use of genetic variation.
Traditional farmers selected higher producing or better tasting
variants and propagated them. The 19th-century advent of plant
breeding exploited variation by use of sexual crosses. The science
of breeding made great progress through the application of
Mendelian, quantitative, and population genetics, heterosis, and
ultimately molecular markers and genomic selection. However,
modern breeders in essence still search for the variation that gives
needed traits and introduce it into their breeding programmes.
The rest is just combining alleles.
However, there is only finite variation within our crop
species, and genetic incompatibility limits the amount that can
be introgressed from outside the species. Moreover, wide
crosses with exotic germplasm can bring, together with the
desired trait such as disease resistance, many undesired traits
such as seed shattering or low yield, which had been earlier
painstakingly bred out of the elite parent. After LJ Stadler
demonstrated the use of X-rays to mutagenize barley and
maize (Stadler, 1930), breeders began to create their own
variation, using random mutagenesis followed by selection,
called ‘mutation breeding’. At the beginning of 2019, the joint
FAO/IAEA mutant variety database (mvd.iaea.org/) contained
3284 plant varieties released in more than 60 countries, which
were either the direct products of mutagenesis or their
progeny. These span at least 214 plant species, including not
only the major cereals and grain legumes, but also oil crops,
fibre crops, herbs, fruits and ornamentals. Prominent examples
include the following: the rice varieties Amaroo (Australia),
Zhefu 802 (China), RD6 and RD15 (Thailand); the malting
barley varieties Diamant and Golden Promise; NIAB-78 cotton
(Pakistan); Rio Star grapefruit (USA).
Gene editing as a response to the off-target
problem of mutagenesis
Chemical mutagens as used in mutation breeding induce
mutations at a frequency ranging from once every 24 kb to
1000 kb (Spencer-Lopes et al., 2018). For example, EMS-induced
mutagenesis in common (hexaploid) wheat induced 104 779
SNPs throughout the genome (Hussain et al., 2018). While
mutagenized populations are good platforms for reverse genetics
(TILLING; Acevedo-Garcia et al., 2017), many back-crosses are
required to purify a specific desired mutation away from the
mutagenized background. In the last few years, genome editing,
a set of highly accurate tools for introducing specific genetic
variations, has been taken into use worldwide. CRISPR/Cas9 is
perhaps the best-known and most widely adopted example of
those tools (Hilscher et al., 2017). The development of genome
editing methods has been widely celebrated in the scientific
community for several reasons. As a research tool, they offer an
efficient platform for analysis of gene function through reverse
genetics. Moreover, they offer a means of knocking out a gene
whose function is known, in order to alter an associated crop trait
(Yin et al., 2017). Recently, the advent of base editing makes
possible the tweaking of gene function, in essence through the
creation of targeted allelic variation (Kim, 2018).
The issue of off-site mutations by CRISPR/Cas9, which together
with a lack of targeting is also the major drawback of chemical-
and radiation-based mutagenesis, has been given attention by
researchers. Editing experiments indicate that off-site mutations
are extremely rare or undetectable (Feng et al., 2018; Lee et al.,
2019), even if potential sites can be identified by software. Given
the low level of off-site mutations, back-crossing of the T0
generation will eliminate the secondary mutations with high
efficiency, unlike for conventionally mutagenized lines.
Allowing fishing by dynamite but forbidding fish hooks
and lures
Given the highly accurate nature of CRISPR/Cas9 -mediated
editing compared to conventional mutagenesis, why did the ECJ
take a laissez faire approach to varieties produced with the latter,
but subject genome-edited varieties to onerous regulation as a
GMOs? The ruling is equivalent to allowing fishing by dynamite
but forbidding fish hooks and lures. Although the Cas9 and guide
RNA (gRNA) construct is often transformed into plants during the
editing process, these can be segregated away in the T1 and
subsequent generations. Moreover, for vegetatively propagated
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crops and perennials, transgenesis-free methods have been
developed (Danilo et al., 2019). To understand why the ECJ
nevertheless regards edited plants as GMOs, regardless of the
presence of the construct, it is useful to look at the ruling. The
judgement of 25 July 2018 (Case C-528/16; http://curia.europa.e
u/juris/documents.jsf?num=c-528/162018) cites Directive 2001/
18 (https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=celex%
3A32001L0018), which regulates GMOs, and applies the ‘pre-
cautionary principle’ for new approaches. However, 2001/18
excludes under its Annex 1B ‘certain techniques of genetic
modification which. . .have a long safety record’ and do not
involve recombinant DNA, in particular mutagenesis.
So how did genome editing as a mutagenesis method fall afoul
of the Court? The trouble appears to be a linguistic and logical
tangle over ‘modification’. Under 2001/18, a GMO is an organism
whose DNA has been altered ‘in a way that does not occur
naturally’. ‘Mutagenesis’ is excluded under 2001/18 if not
involving the use of a ‘genetically modified organism’. Now, the
Court finds that the editing techniques in particular alter DNA in
‘a way that does not occur naturally’ and therefore gener-
ate GMOs. This is because while Annex 1 A and Annex 1 B of
2001/18 include only recombinant methods in vitro or in vivo as
well as cell fusion as making GMOs, they do not explicitly exclude
mutagenesis because it is not included in the list not making
GMOs (e.g., in vitro fertilization, polyploidy induction). Moreover,
2001/18 held mutagenesis as a ‘technique of genetic modifica-
tion’, even if not leading to a GMO. So the Curia uses the original
confusions in 2001/18, whereby DNA can be modified but not
result in a genetically modified organism under law if the method
used had been ‘conventional’ with a ‘long safety record’. It holds
that the risks of new mutagenesis techniques possibly may be the
same as those of transgenesis, that the alterations are ‘unnatural’,
so therefore the precautionary principle holds and the new
methods must be regulated like transgenesis. Thus, the judges,
ignoring the science, forced genome editing under the outmoded
Directive 2001/18.
The idea that a technique, which uses a process found in
nature, is ‘unnatural’ is illogical. The idea that a single mutation
could pose risks, which the same mutation mixed in with a
thousand others does not pose, is nonsensical. The older,
scattershot methods introduce random changes throughout the
DNA, many of which remain in the final variety placed on the
market and have undetermined effects. In contrast, genome
editing is highly accurate and can only be undertaken with precise
knowledge of the target gene. Thus, it is a wonderment that the
ECJ ignored the statements of EU advice bodies, both the
Scientific Advice Mechanism (SAM) of the European Commission
and the European Food Safety Agency (EFSA), which held edited
plants to be equivalent to those produced by conventional means.
In contrast to the final EJC view, the preliminary ruling of EU
Advocate General Michal Bobek (http://curia.europa.eu/juris/d
ocument/document.jsf?text=&docxml:id=198532&pageIndex=
0&docxml:lang=EN) did suggest a channel by which genome-
edited plants might be outside the regulatory framework but
nevertheless GMOs. His opinion is based on two principles: first,
triggering of the precautionary principle must be based on broad
scientific data and not merely fear of risk; second, the definition
of mutagenesis cannot be fixed to its meaning at the turn of the
millennium, just as that of ‘vehicle’ or ‘means of communication’
cannot be restricted to their sense of two centuries ago, but
rather be adjusted to include newer approaches. Hence, like
conventional mutagenized lines, edited lines would outside the
regulatory framework of 2001/18, however, with the reservations
that new methods must ‘. . .not involve the use of recombinant
nucleic acid molecules or GMOs’. These caveats are very unclear,
because Bobek defines neither ‘involvement’ nor ‘recombinant’.
His view appears to differ from 2001/18 itself (Annex 1A Part 1
(1)), whereby the recombinant nucleic acids in regulated GMOs
must be ‘incorporated’ where they ‘do not naturally occur’ and
be ‘capable of continued propagation’. In any case, the EJC finally
maintained a premodern view of mutagenesis.
Response to the ECJ ruling
The response to the ruling among the worldwide scientific
community has been universally excoriating. The European Plant
Science Organisation (EPSO), representing 200 research institu-
tions from 30 countries and over 26 000 people working in plant
science, expressed disappointment and noted the lost opportuni-
ties for Europe. A consortium of 116 European research institu-
tions spearheaded by VIB/University of Ghent sent an open letter
to EC President Jean-Claude Juncker detailing their deep concern
over the downsides. A coalition of 13 countries from around the
world issued a statement at an autumn 2018 WTO meeting,
supporting policies that enable innovation by genome editing.
Consequences of the ruling
European Parliament and Council Directives need to be ‘trans-
posed’, that is, implemented in national law, for which the ECJ
ruling will cause no end of trouble. The ruling will be impossible
to enforce because edited plant varieties are indistinguishable
from ones derived from chemical or radiation mutagenesis or
from crosses to exotic germplasm. So Member States will find it
difficult to enforce laws based on Directive 2015/412, the
extension of 2001/18 that allows them to prohibit cultivation of
genetically modified crops on part or all of their territories. Two
cultivars with identical nucleotide changes, one made by editing
and the other not, neither with exogenous DNA, will need to be
separately regulated under the law. Foods that contain more than
0.9% GMOs should be labelled for sale in the EU; however,
edited ingredients will not be identifiable by their DNA. Foreign
producers in countries not regulating genome-edited crops as
GMOs (Table 1) have no legal responsibility to track or label
them; either all food products from such sources will need to be
banned, or the ruling will be meaningless. This has the potential
to raise serious international trade issues.
The decision by the ECJ is moreover simply bad policy for Europe.
Big agribusiness has the expertise and deep pockets to overcome the
regulatory hurdles of GMO legislation. In fact, the judgement gives
them an open playing field by restricting the entry of small players,
such as many breeders in Europe. Permission only to import a GMO
on average can cost €11 m–€16.7 m and take 6 years (https://
www.europabio.org/agricultural-biotech/faq/gmos-and-the-eur
opean-union/how-long-does-it-take-gm-crop-import-be-approved-
and-how-much-does-cost). Given that at least 15gene-editedplants,
most from small players, had been developed by 2018 in the United
States alone (https://www.theparliamentmagazine.eu/articles/part
ner_article/europabio/how-europe-has-priced-out-innovation-exa
mple-plants), solutions to make crops more sustainable, healthy,
healthful and productive will be sought outside Europe. Statements
by several large breeders indicate that they will either breed edited
crops for markets outside Europe, move their editing research from
Europe, or both (https://european-biotechnology.com/up-to-date/
backgrounds-stories/story/cjeu-ruling-triggers-exodus-of-eu-plant-re
search.html). The growing list of countries (Table 1) that have either
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excluded genome-edited varieties from GMO regulations or that
implement product- and not process-based regulations grows by the
month, leaving the EU increasingly isolated. Moreover, the paper-
work and delays imposed on academic research and field trials will
have a chilling effect, driving talent and innovation from Europe. In
sum, novel crops will be developed for growing conditions outside of
Europe by breeders outside Europe, with research and investment
likewise directed elsewhere. European food producers will fail to
receive locally sourced raw ingredients with improved and novel
qualities to meet public needs.
How forward?
Europe and the rest of the world face enormous agricultural
challenges. Meeting sustainable development goals for a popu-
lation of 9.7 billion projected for 2050 with less fertilizer, a fixed
water budget, on less land, and under a changing climate will
require novel cultivars as rapidly as possible. Genome editing is a
green solution, one of many tools that plant scientists, breeders,
and farmers desperately need now. As the 116-institution letter
to Juncker stated and EPSO likewise holds, the next Commission
must urgently prioritize the matter, and plants with small genetic
changes and no foreign genes must be outside of the regulatory
regime. Ultimately, EU GMO regulations urgently need updating
to a product-based and not method-based system. Current
mutation-derived crops are cultivated on tens of millions of
hectares. Likewise, edited varieties with targeted, knowledge-
based changes can help to provide a secure, economically and
environmentally sustainable food supply to all the world, should
the regulatory authorities choose to rely on evidence for their
decisions. Such crops are appearing outside Europe already; it is
time for Europe to bring the benefits of its research investment in
the plant sciences home.
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Table 1 Current regulatory status of plant genome editing for
selected countries outside the EU
Region/
country
Current genome editing
status
Example products in market
pipeline
North America
Canada Product-, not technology-
based.
USA Not GMO At least 20 products, including
high-oleic-acid soy oil; high-
fibre wheat; alfalfa; cold-
storable potato; reduced-
browning potato; coeliac-
friendly wheat; maize with
waxy starch
South America
Argentina Not GMO At least 10 pending plant
varieties
Brazil Not GMO Cacao
Chile Not GMO
Columbia Not GMO Micro-Tom tomatoes
Honduras Not GMO
Paraguay Not GMO
Uruguay Expected to harmonize with
other South American
countries
Other
Australia Editing without template
not regulated as GMO
Israel Not GMO if no transgene
Japan Not GMO
New
Zealand
GMO
Norway Not regulated as GMO if
change can occur by
conventional methods
Philippines Not GMO
Russia New decree exempts GE
crops from GM regulations
Switzerland Draft revision to GMO law
expected 2019
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